Aurobindo Pharma expands its presence in France with the launch of Arrow Pharma Production SAS for generic formulation manufacturing.
SENSEX 75,415.35
+ 231.99
NIFTY 23,719.30
+ 64.60
CRUDEOIL 9,363.00
Aurobindo Pharma Q4 net up 2% to ₹921 cr
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Rahul Shah bullish on pharma, sees Sun Pharma and Aurobindo as key large-cap plays
AFT Pharmaceuticals lifts its 2027 revenue target to above $300 million
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividend
Nykaa shares in focus after Q4 profit surges 286%, revenue rises 28%
Aurobindo Pharma reports Q4 net profit rise to ₹921 crore, driven by strong European market performance and overall revenue…
Aurobindo Pharma surpasses Dr Reddy's in FY26 revenue, becoming the second-largest Indian pharma company.
Aurobindo Pharma reports a 2% net profit rise to ₹921 crore with total revenue growing 5.6% to ₹8,853 crore in Q4.
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs…
Secondo la testata "La Lettre", a inizio dicembre alcuni rappresentati della società farmaceutica americana hanno avuto contatti…
Jubilant Pharmova reports 14% revenue growth in FY26, driven by strong performance in sterile injectables despite margin…
